Outsourced Pharma Capacity Update Videos - Large Molecule

  1. Scorpius Biomanufacturing Capacity Update July 2024: Large Molecule Development 8/14/2024

    Scorpius' VP of Manufacturing Operations Matt LeClair presents a 3D virtual tour of the process development lab, analytical and QC lab, and the mammalian manufacturing upstream and cell culture suites.

  2. KBI Biopharma Capacity Update May 2024: Large Molecule Development 6/12/2024

    Discover how our development and platform-based manufacturing solutions can create an unobstructed path to market for your large molecule pipeline in a dynamic regulatory environment.

  3. JOINN Biologics Capacity Update May 2024: Large Molecule Development 6/12/2024

    JOINN Biologics US Inc. is a California-based CDMO that provides our customers with flexible solutions for complex biologics, including ADCs. JOINN Biologics is a combination of "Big Pharma Infrastructure" with 200L and 1000L traditional stainless steel bioreactors combined with new state of the art single use bioreactors at the 50L, 200L and 500L scale.

  4. EirGenix Capacity Update May 2024: Large Molecule Development 6/12/2024

    EirGenix has immediate capacity availability up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial. The microbial capacity will increase to 350L and 1,000L by 2025.

  5. Singota Solutions Capacity Update May 2024: Large Molecule Development 6/11/2024

    Review our Analytical, Product and Process Development, and Manufacturing capabilities along with the knowledge required to demonstrate product and process understanding.

  6. AGC Biologics Capacity Update May 2024: Large Molecule Development 6/11/2024

    Learn more about our global Biologics network, track record, and capabilities. Plus, take a detailed look at our Copenhagen site and how we balance flexibility with scale to meet the demands of clients.

  7. Scorpius Biomanufacturing Capacity Update May 2024: Large Molecule Development 6/11/2024

    Our facility offers ~2,000 sq. ft. of process and analytical development labs and ~8,600 sq. ft. of cGMP-compliant cleanroom manufacturing space for mammalian and microbial programs.

  8. Mabion Capacity Update May 2024: Large Molecule Development 6/11/2024

    Review our installations in upstream development, downstream development, and fill & finish. Our EU-GMP certified facility is staffed by a team of 250 professionals and focuses on providing CDMO services.